A new, powerful Citizen Portal experience is ready. Switch now

Senate passes S.B. 122 to create affirmative defense for syringe exchange participants

February 06, 2023 | 2023 Utah Legislature, Utah Legislature, Utah Legislative Branch, Utah


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Senate passes S.B. 122 to create affirmative defense for syringe exchange participants
The Senate on the floor approved first substitute S.B. 122, a bill the sponsor said creates an affirmative defense for individuals who possess syringes because they participate in syringe exchange programs.

Sponsor Senator Plumb described the measure as a compromise developed with syringe‑access programs, law enforcement, the health department and medical stakeholders. "Basically, what this would do would make it so that if someone possesses syringes and they're doing the safest thing possible ... that they would be eligible for an affirmative defense instead of a paraphernalia charge," Plumb said.

Floor sponsors also offered amendment #1 to add a code pathway to verify participation in a syringe exchange program. The amendment was adopted unanimously on the floor and the Senate then read the amended bill for a third time; the clerk reported 22 yay votes, 0 nay votes, with 7 absent, and the bill passed.

What happens next: With the Senate's passage, the amended S.B. 122 will be transmitted to the House for consideration. The bill's language now includes a verification mechanism for exchange participation as adopted in the floor amendment.

Don't Miss a Word: See the Full Meeting!

Go beyond summaries. Unlock every video, transcript, and key insight with a Founder Membership.

Get instant access to full meeting videos
Search and clip any phrase from complete transcripts
Receive AI-powered summaries & custom alerts
Enjoy lifetime, unrestricted access to government data
Access Full Meeting

30-day money-back guarantee